Clinical Trial Update: Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the long-term safety of Treximet (sumatriptan/naproxen) in adolescents with migraine has completed; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2010-09-06